The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8
mBio · 2024
DOI: 10.1128/mbio.02320-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Lujie Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, COVID-19. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-structural proteins (NSPs) play a crucial role in the replication of severe acute respiratory syndrome coronavirus 2, facilitating virus amplification and propagation. In this study, we conducted a comprehensive investigation into the stability of all subunits comprising the RNA-dependent RNA polymerase complex. Notably, our results reveal for the first time that NSP8 is a relatively unstable protein, which is found to be readily recognized and degraded by the proteasome. This degradation process is mediated by the host E3 ligase tripartite motif containing 22 (TRIM22), which is also a member of the interferon stimulated gene (ISG) family. Our study elucidates a novel mechanism of antiviral effect of TRIM22, which utilizes its own E3 ubiquitin ligase activity to hinder viral replication by inducing ubiquitination and subsequent degradation of NSP8. These findings provide new ideas for the development of novel therapeutic strategies. In addition, the conserved property of NSP8 raises the possibility of developing broad antiviral drugs targeting the TRIM22-NSP8 interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, China.
- Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…
- Department of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Guangdong Key laboratory for Anti-infection Drug Quality Evaluation, Shenzhen, Guangdong, China.
- Shenzhen Research Center for Communicable Disease Diagnosis, Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong, China.
ORCID-Profile: Lujie Fan, Lei Liu, Gang Xu, Zheng Zhang
Zitieren
APA
Fan, L., Zhou, Y., Wei, X., Feng, W., Guo, H., Li, Y., Gao, X., Zhou, J., Wen, Y., Wu, Y., Shen, X., Liu, L., Xu, G., & Zhang, Z. (2024). The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8. mBio. https://doi.org/10.1128/mbio.02320-23
Vancouver
Fan L, Zhou Y, Wei X, Feng W, Guo H, Li Y, et al. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8. mBio. 2024. doi:10.1128/mbio.02320-23
BibTeX
@article{Fan2024,
author = {Fan, Lujie and Zhou, Yuzheng and Wei, Xiafei and Feng, Wei and Guo, Huimin and Li, Yunfei and Gao, Xiang and Zhou, Jian and Wen, Yanling and Wu, Yezi and Shen, Xiaotong and Liu, Lei and Xu, Gang and Zhang, Zheng},
title = {The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.02320-23}
}
EUVIMED